Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan

The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.558 per share on May 7, 2025, according to a Form 4 filing.

Summary

• The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock on May 7, 2025.
• The sale was executed at a price of $82.558 per share.
• The transaction was made pursuant to a pre-arranged trading plan under Rule 10b5-1(c).
• Following the transaction, the W.K. Kellogg Foundation Trust beneficially owns 46,816,199 shares of Kellanova.
• The Northern Trust Company is a corporate trustee of the W.K. Kellogg Foundation Trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a pre-planned stock sale. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales by major shareholders, especially those related to foundations, are common and often pre-planned to provide liquidity for their charitable activities. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Rule 10b5-1 plans are a common tool used by corporate insiders and major shareholders to diversify their holdings or meet liquidity needs without raising concerns about trading on non-public information.
• Comparable transactions would include similar filings by other large institutional holders of publicly traded companies, such as university endowments or charitable foundations.
• The size of the transaction (114,583 shares) is relatively small compared to the total shares outstanding, suggesting it's a routine portfolio adjustment rather than a significant strategic shift.

Stakeholder Impact

• The sale of shares by the W.K. Kellogg Foundation Trust may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small size of the transaction.
• The proceeds from the sale will likely benefit the W.K. Kellogg Foundation's charitable activities.

Key Dates

Keywords

Kellanova, Kellogg W K Foundation Trust, Form 4, Share Sale, 10b5-1 Plan, Beneficial Ownership, Securities Exchange Act